Kane Biotech Inc. (CVE:KNE – Get Free Report) shares traded down 18.6% during mid-day trading on Wednesday . The stock traded as low as C$0.04 and last traded at C$0.04. 546,500 shares changed hands during trading, an increase of 614% from the average session volume of 76,569 shares. The stock had previously closed at C$0.04.
Kane Biotech Trading Down 18.6%
The company has a debt-to-equity ratio of -331.42, a current ratio of 0.80 and a quick ratio of 0.39. The stock has a market cap of C$5.04 million, a price-to-earnings ratio of 0.88 and a beta of 0.52. The company’s fifty day moving average price is C$0.04 and its 200-day moving average price is C$0.07.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- What is the NASDAQ Stock Exchange?
- Vertical Aerospace: An Analyst’s Roadmap to a Potential Re-Rating
- Short Selling – The Pros and Cons
- New Global Deals Boost These 2 Defense Leaders
- The 3 Best Blue-Chip Stocks to Buy Now
- MP Materials: How One Move Redefined the U.S. Magnet Supply Chain
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
